Highlights
- CES iBioTech rocketed 14.1 per cent with the rising popularity of medical and pharmaceutical stocks
- CES P Elite rose 2.1 per cent as equity transactions increased among overseas listed Mainland private enterprises
- Stocks and currencies of emerging markets came under pressure
- PBC moved to stimulate cross-border fund flows
- Xiaomi said to be first company to use CDR
- Commodity connectivity would give China more influence in metals pricing
Click here for full details.
